North America Laboratory Centrifuges Market
The North America Laboratory Centrifuges Market is witnessing significant growth due to increasing demand for clinical diagnostics, advancements in centrifuge technology, and the expanding biopharmaceutical sector. Laboratory centrifuges play a vital role in separating various components of liquids in research, clinical, and industrial settings. The integration of automation and digital controls is further enhancing efficiency and data management. The market is projected to observe robust growth through 2035, driven by innovation and rising healthcare needs across the US, Canada, and Mexico.
Understanding the Impact of Tariffs on "North America Laboratory Centrifuges Market".
Latest Market Dynamics
Key Drivers
- Rising demand for advanced diagnostic solutions in clinical laboratories, notably by Thermo Fisher Scientific’s 2025 launch of enhanced benchtop centrifuges.
- Expanding biopharmaceutical and biotechnology sectors, as seen through Eppendorf AG’s continued investments in North American manufacturing and R&D facilities.
Key Trends
- Automation and digitalization of laboratory equipment, demonstrated by Beckman Coulter’s smart centrifuge solutions introduced in 2025, streamlining workflow and boosting reproducibility.
- Focus on energy-efficient and environmentally friendly centrifuges, with Danaher Corporation introducing new ultracentrifuge models featuring reduced energy consumption.
Key Opportunities
- Surging investments in precision medicine, with academic and research institutions investing in high-speed and ultracentrifuges for genomics and proteomics applications.
- Expansion of online retail and direct sales channels, as companies like OHAUS Corporation enhance their e-commerce capabilities to reach a broader customer base.
Key Challenges
- High procurement and maintenance costs restricting access, particularly for small and medium organizations, as highlighted by Labconco Corporation’s focus on financing solutions.
- Complex regulatory landscape, with QIAGEN N.V. navigating region-specific compliance and certification requirements for new centrifuge models.
Key Restraints
- Increased competition from low-cost manufacturers creating pricing pressures, evident in Sartorius AG’s adjustments in product line pricing.
- Limited trained personnel for operating advanced centrifuges in labs, with Becton, Dickinson and Company initiating training programs across select North American regions.
North America Laboratory Centrifuges Market Share (%) by Type, 2025
Benchtop centrifuges dominate the North America market, accounting for 32% of the share in 2025, driven by their compact design and broad application in research and diagnostics. Ultracentrifuges and microcentrifuges follow, valued for high-speed protocols in biotechnology and cellular studies. The adoption of floor-standing and clinical centrifuges is rising in hospitals and large clinical labs due to higher throughput requirements. Increasing R&D in the biopharma sector and greater funding for laboratory automation further support growth across these segments.
North America Laboratory Centrifuges Market Share (%) by Applications, 2025
Hospitals retain the largest application share at 29% in 2025, leveraging centrifuges extensively in clinical diagnostics and blood banking. Biotechnology and pharmaceutical companies follow at 24%, reflecting increased product development and biologics research. Clinical laboratories and academic institutions are also significant contributors, underlining the critical role of centrifuges in diverse scientific and healthcare workflows. Overall, demand is being driven by the need for precise and rapid sample processing in a variety of healthcare and research environments.
North America Laboratory Centrifuges Market Revenue (USD Million), 2020-2035
The market revenue for laboratory centrifuges in North America experienced consistent growth from USD 1,560 Million in 2020 to a projected USD 2,720 Million by 2035. The rise is attributed to technological upgrades, increased research investments, and healthcare expansion. The upward trend indicates robust opportunities driven by expanding laboratory infrastructure and adoption of next-gen centrifuge solutions.
North America Laboratory Centrifuges Market YOY (%), 2020-2035
Year-over-year growth rates showed moderate to strong expansion, with a peak of 5.1% in 2025 driven by post-pandemic research acceleration. Growth gradually moderates, reflecting overall market maturity by 2030 onward, but remains steady due to continuous technological advancements and investment in healthcare infrastructure.
North America Laboratory Centrifuges Market Share (%) by Regions, 2025
The United States leads the regional share with 67%, reflecting its extensive laboratory and healthcare infrastructure. Canada and Mexico contribute 20% and 13% respectively, driven by ongoing investments in life sciences and government-supported research. The market outlook remains positive across all countries, backed by growing biotechnology sectors and improved access to laboratory equipment.
North America Laboratory Centrifuges Market Players Share (%), 2025
Thermo Fisher Scientific and Eppendorf AG account for the largest shares at 25% and 18% in 2025, benefitting from broad portfolios and long-standing industry relationships. Other key players, including Beckman Coulter, Danaher Corporation, and Sartorius AG collectively represent a significant portion of the competitive landscape, focusing on innovation, automation, and customized solutions to maintain market prominence.
North America Laboratory Centrifuges Market Buyers Share (%), 2025
Hospitals and large clinical laboratories dominate buyer share at 30% and 22%, indicative of robust procurement for diagnostics and research. Pharmaceutical and biotech companies represent 20% of purchases, followed by academic and research institutions at 15%. The presence of government and public health organizations further diversifies the market’s buyer landscape, ensuring a stable demand base.
Study Coverage
| Metrics | Details |
|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 1800 |
| Regions | United States, Canada, Mexico |
| Segments | By Type (Benchtop Centrifuges, Floor-standing Centrifuges, Microcentrifuges, Ultracentrifuges, Clinical Centrifuges, Haematocrit Centrifuges), By Application (Hospitals, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Blood Banks, Clinical Laboratories, Others), By Distribution Channels (Direct Sales, Distributors/Wholesalers, Online Retailers, Specialty Stores, Third Party Distributors, Others), By Technology (Refrigerated, Non-refrigerated, High-speed, Low-speed, Vacuum, Others), By Organization Size (Small, Medium, Large) |
| Players | Thermo Fisher Scientific, Eppendorf AG, Danaher Corporation, Sigma Laborzentrifugen GmbH, Andreas Hettich GmbH & Co. KG, QIAGEN N.V., OHAUS Corporation, Labconco Corporation, Sartorius AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Kubota Corporation, NuAire, Inc., REMI Group, HERMLE Labortechnik GmbH |
Key Recent Developments
- In June 2024, Thermo Fisher Scientific announced the launch of its new Energy-Efficient Benchtop Centrifuge series for diagnostics and research labs.
- In July 2024, Beckman Coulter introduced smart-connected centrifuge models with enhanced automation and real-time monitoring features.
- In August 2024, Eppendorf AG expanded its manufacturing facility in Connecticut, increasing product output for North America.
- In September 2024, Danaher Corporation released a portfolio of ultracentrifuges featuring advanced rotor technology for faster separation.
- In October 2024, OHAUS Corporation launched an upgraded online portal for direct purchasing and technical support for laboratories.
